Nasdaq Earnings

Fast casual restaurant Wingstop Inc. (NASDAQ: WING) stock has been defying all odds screaming to a new all-time high of $193 on Feb. 22, 2023. A combination of solid earnings and a short squeeze has caused shares to resist the macroeconomic market pressures. It competes with oth

Novavax is set to report fourth quarter fiscal 2022 earnings results before the opening bell Tuesday.

Nio reports its fourth quarter fiscal 2022 earnings before the opening bell Wednesday.

Data from Citigroup points to traders taking a more bearish stance as they added nearly $3 billion of new shorts to S&P 500 futures last week.

The following companies are expected to report earnings prior to market open on 02/28/2023. Visit our Earnings Calendar for a full list of expected earnings releases.Target Corporation (TGT)is reporting for the quarter ending January 31, 2023. The discount retail company's conse

The following companies are expected to report earnings prior to market open on 02/28/2023. Visit our Earnings Calendar for a full list of expected earnings releases.Target Corporation (TGT)is reporting for the quarter ending January 31, 2023. The discount retail company's conse

The following companies are expected to report earnings after hours on 02/27/2023. Visit our Earnings Calendar for a full list of expected earnings releases.Occidental Petroleum Corporation (OXY)is reporting for the quarter ending December 31, 2022. The oil company's consensus e

Cruise line stocks have risen sharply since the onset of the pandemic. Royal Caribbean Group (NYSE: RCL) stock is up 294%. Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) is up 188%. And Carnival Cruise Lines (NYSE: CCL) is up 124%. And recent analysts' opinions suggest these s

Plant-based meat alternatives are growing in popularity, and that could make them a solid long-term investment as well. This is particularly true for the many new publicly-traded vegan food companies today. As reported in a story last week, Beyond Meat Inc. (NASDAQ: BYND) shares

As we wind down February, the market’s level of certainty regarding the Fed’s response to the macro-economic picture, especially inflation went from fairly high to far more uncertain.

As the global travel industry booms, increased U.S. market share helped Booking Holdings Inc. (NASDAQ: BKNG) beat consensus estimates in its fourth-quarter report.  Anybody who’s flown recently has experienced firsthand the fast rebound in travel after pandemic restrictions were

As the global travel industry booms, increased U.S. market share helped Booking Holdings Inc. (NASDAQ: BKNG) beat consensus estimates in its fourth-quarter report.  Anybody who’s flown recently has experienced firsthand the fast rebound in travel after pandemic restrictions were

Digital signature cloud company DocuSign Inc. (NASDAQ: DOCU) stock got clobbered on the Sell rating by UBS on Feb. 21, 2023. The company is arguably the leader in digital eSignatures and offers additional services that lead to complete contract lifecycle management. The company

Sometimes investors would like more choices than what’s on our dividend kings and aristocrats list. So this week, we discussed upcoming dividend aristocratsand why investors should consider adding them to their portfolios. But today, we are serving up the main course with these

Between the collapse in natural gas prices and the downtrend in oil, energy stocks don't look as attractive as they did back in the summer. In the meantime, one corner of the oil and gas industry is bucking the trend: product tankers. Put, product tankers like Scorpio Tankers (N

Novavax, Nio, and Plug Power are among the companies reporting earnings this week.

The following companies are expected to report earnings prior to market open on 02/27/2023. Visit our Earnings Calendar for a full list of expected earnings releases.Li Auto Inc. (LI)is reporting for the quarter ending December 31, 2022. The auto (foreign) company's consensus ea

It is no surprise that the combined weight of elevated inflation, rising interest rates and uncertainty about the economy have forced consumers to change their spending behavior.

Pfizer Inc. (NYSE: PFE) may have ten blockbuster drugs in its pipeline, but it seems much of the company’s near-term potential could be based on the success of two important Phase 3 studies.  Analysts anticipate the approval of these two drugs could add at least another $1 billi

These figures build on other recent inflation data, indicating inflation pressure has been more resilient than expected despite the Fed’s efforts thus far. The January PCE Price Index is expected to tick lower to 4.8% from 5% in December with the core reading inching lower to 4.3